Cortellaro M - Search Results

1

Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.

Cofrancesco E, Cortellaro M, Corradi A, Ravasi F, Bertocchi F. Cofrancesco E, et al. Among authors: cortellaro m. Thromb Haemost. 1998 Mar;79(3):509-10. Thromb Haemost. 1998. PMID: 9531030 Clinical Trial.

2

Markers of hemostatic system activation during thromboprophylaxis with recombinant hirudin in total hip replacement.

Cofrancesco E, Cortellaro M, Leonardi P, Corradi A, Ravasi F, Bertocchi F. Cofrancesco E, et al. Among authors: cortellaro m. Thromb Haemost. 1996 Mar;75(3):407-11. Thromb Haemost. 1996. PMID: 8701398 Clinical Trial.

3

Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery.

Cofrancesco E, Cortellaro M, Corradi A, Ravasi F, Bertocchi F. Cofrancesco E, et al. Among authors: cortellaro m. Thromb Haemost. 1997 Feb;77(2):267-9. Thromb Haemost. 1997. PMID: 9157579 Clinical Trial.

4

Preoperative plasma levels of prothrombin fragment 1 + 2 correlate with the risk of venous thrombosis after elective hip replacement.

Corradi A, Lazzaro F, Cofrancesco E, Cortellaro M, Ravasi F, Bertocchi F. Corradi A, et al. Among authors: cortellaro m. Acta Orthop Belg. 1999 Mar;65(1):39-43. Acta Orthop Belg. 1999. PMID: 10217000

5

Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study.

Cortellaro M, Cofrancesco E, Arbustini E, Rossi F, Negri A, Tremoli E, Gabrielli L, Camera M. Cortellaro M, et al. Thromb Haemost. 2002 Jul;88(1):41-7. Thromb Haemost. 2002. PMID: 12152675 Clinical Trial.

6

Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT Group.

Cortellaro M, Cofrancesco E, Boschetti C, Mussoni L, Donati MB, Catalano M, Gabrielli L, Lombardi B, Specchia G, Tavazzi L, et al. Cortellaro M, et al. Thromb Haemost. 1994 Aug;72(2):292-6. Thromb Haemost. 1994. PMID: 7831667

7

Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in Combination Treatment.

Cortellaro M, Cofrancesco E, Boschetti C, Cortellaro F, Mancini M, Mariani M, Paoletti R. Cortellaro M, et al. Among authors: cortellaro f. Thromb Haemost. 2000 Apr;83(4):549-53. Thromb Haemost. 2000. PMID: 10780315 Clinical Trial.

8

High fibrinopeptide A levels modified by heparin in acute nonlymphocytic leukemia.

Pogliani EM, Cofrancesco E, Salvatore M, Boschetti C, Cortellaro M. Pogliani EM, et al. Among authors: cortellaro m. Thromb Haemost. 1985 Oct 30;54(3):727. Thromb Haemost. 1985. PMID: 4089802 No abstract available.

9

Association of lipoprotein(a) with atherothrombotic events and fibrinolytic variables. A case-control study.

Franceschini G, Cofrancesco E, Safa O, Boschetti C, Tremoli E, Mussoni L, Sirtori CR, Cortellaro M. Franceschini G, et al. Among authors: cortellaro m. Thromb Res. 1995 May 1;78(3):227-38. doi: 10.1016/0049-3848(95)00052-s. Thromb Res. 1995. PMID: 7631303

10

Dermatan sulphate for the treatment of disseminated intravascular coagulation (DIC) in acute leukemia: a randomised, heparin-controlled pilot study.

Cofrancesco E, Boschetti C, Leonardi P, Gianese F, Cortellaro M. Cofrancesco E, et al. Among authors: cortellaro m. Thromb Res. 1994 Apr 1;74(1):65-75. doi: 10.1016/0049-3848(94)90036-1. Thromb Res. 1994. PMID: 8029809 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters